Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Merve Özkan
Observed names:
M. Özkan,
Merve Ozkan
Institution:
Izmir Kâtip Çelebi University
Observed institution:
Izmir Kâtip Çelebi University
ORCID:
0000-0002-2202-5159
Observed ORCID:
0000-0002-2202-5159
OpenAlex ID:
A5013593639
Regorafenib therapy as a third-line treatment for metastatic colorectal cancer: A single center long term experience
2023
·
Merve Ozkan
, Utku Oflazoglu
, et al.
·
Medicine
·
2
Kara Kohoş Otu (Cimicifuga Racemosa)
2024
·
Merve Özkan
·
Akademisyen Kitabevi eBooks
Immunotherapy for Breast Cancer Survivors: Implications for Clinical Practice
2024
·
Merve Özkan
·
Springer eBooks
49P Treatment management in RAS and BRAF mutations in patients with metastatic colorectal cancer
2023
·
M. Özkan
, Y. Yildiz
, et al.
·
ESMO Open
Berlin-Frankfurt-Munster (BFM) versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone (Hyper-CVAD) chemotherapy regimens in Adult T-Cell ALL and Adolescent and Young Adult (AYA) Patients
2022
·
Merve Özkan
, Şerife Solmaz
, et al.
·
Eurasian Journal of Medical Advances
PDF
Show more works
View as search
Works count:
5
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type